The role of estrogen in the treatment of Alzheimer's disease

Neurology

Volumn 48, Issue 5 SUPPL. 7, 1997, Pages

  Birge, Stanley J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL BENZOATE; ESTROGEN; PLACEBO; TACRINE; TESTOSTERONE PROPIONATE;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL TRIAL; DEMENTIA; DRUG EFFECT; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030942683     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.5_suppl_7.36s     Document Type: Article

References (55)

1. Sullivan JM, Vander Zwaag R, Hughes JP, et al. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-2562.
2. Gilligan DM, Quyyumi AA, Cannon RO, III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-2551.
3. Polderman KH, Stehouwer CD, van Kamp GJ, et al. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-432.
4. Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;167:828-833.
5. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-1687.
6. Gangar KF, Vyas S, Whitehead M, et al. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-842.
7. Ohkura T, Teshima Y, Isse K, et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1994;2:13-18.
8. Second symposium on aging and aging disorders: Stockholm, 1993. Dementia 1994;5:129-213.
9. O'Brien MD. How does cerebrovascular disease cause dementia? Dementia 1994;5:133-136.
10. O'Brien C. Auguste D. and Alzheimer's disease [news]. Science 1996;273:28.
11. Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992;13:483-491.
12. Zhang WW, Badonic T, Hoog A, et al. Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Dementia 1994;5:153-162.
13. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen therapy and stroke: a prospective study. Br Med J 1988;297:519-522.
14. Falkeborn M, Persson I, Terent A, et al. Hormone replacement therapy and the risk of stroke: follow-up of a population-based cohort in Sweden. Arch Intern Med 1993;153:1201-1209.
15. Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990;97:1080-1086.
16. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
17. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756-762.
18. Funk JL, Mortel KF, Meyer JS. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 1991;2:268-272.
19. Toran-Allerand CD. On the genesis of sexual differentiation of the central nervous system: morphogenic consequences of steroidal exposure and possible role of α-fetoprotein. Prog Brain Res 1984;61:63-98.
20. Arimatsu Y, Hatamaka H. Estrogen treatment enhances survival of cultured amygdala neurons in a defined medium. Dev Brain Res 1986;26:151-159.
21. Faivre-Bauman A, Rosenbaum E, Puymirat J, et al. Differentiation of fetal mouse hypothalamic cells in serum-free medium. Dev Neurosci 1981;4:118-129.
22. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-2554.
23. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293-306.
24. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644:305-312.
25. Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993;17:23-29.
26. Singh M, Meyer EM, Simpkins JW. Ovariectomy reduces ChAT activity and NGF mRNA levels in the frontal cortex and hippocampus of the female Sprague-Dawley rats [abstract]. Soc Neurosci Abstr 1994;514.11:1254.
27. Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-2324.
28. Hefti F, Hartikka J, Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 1989;10:515-533.
29. Fisher WI, Wictorin K, Bjorklund A, et al. Intracerebral infusion of nerve growth factor ameliorates cholinergic neuron atrophy and spatial memory impairments in aged rats. Nature 1987;329:65-68.
30. Sohrabji F, Miranda RC, Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994;14:459-471.
31. Regland B, Gottfries CG. The role of amyloid beta-protein in Alzheimer's disease. Lancet 1992;340:467-469.
32. Sisodia SS, Koo EH, Beyreuther K, et al. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990;248:492-495.
33. Armstrong RA. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995;6:121-125.
34. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid beta-precursor protein. J Biol Chem 1994;269:13065-13068.
35. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
36. Akesson HO. A population study of senile and arteriosclerotic psychoses. Hum Hered 1969;19:546-566.
37. Molsa PK, Marttila RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand 1982;65:541-552.
38. Schoenberg S, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22:724-729.
39. Kokmen E, Chandra V, Schoenberg BS. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988;38:975-980.
40. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
41. Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia: age-dependent incidence, prevalence, and mortality in the old. Arch Intern Med 1991;151:989-992.
42. Hubbard B, Anderson J. Sex differences in age-related brain atrophy [letter]. Lancet 1983;1:1447-1448.
43. Grady CL, Rapport SI. Cerebral metabolism in aging and dementia. In: Birren JE, Sloane RB, Cohen GD, eds. Handbook of mental health and aging, 2nd ed. San Diego: Academic Press, 1992:201-228.
44. Bishop J, Singh M, Bodor ET, Simpkins JW. Estradiol stimulates glucose uptake and has cytoprotective effects in rat C6 glioma cells [abstract]. Soc Neurosci Abstr 1994;20.
45. Bishop J, Simpkins JW. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull 1995;36:315-320.
46. Caldwell BM. An evaluation of psychological effects of sex hormone administration in aged women. J Gerontol 1954;9: 168-174.
47. Kantor HI, Michael CM, Shore H. Estrogen for older women. Am J Obstet Gynecol 1973;116:115-118.
48. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer's type). Psychoneuroendocrinology 1986;11:337-345.
49. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system - senile dementia (Alzheimer's type). J Steroid Biochem Mol Biol 1989;34:521-525.
50. Ohkura T, Isse K, Akazawa K, et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995;6:99-107.
51. Rice MM, Graves AB, McCurry SM, et al. Estrogen replacement therapy and cognitive function in Japanese American women: potential mitigating factors. Unpublished data.
52. Briton RD. Equilin, a major component of the estrogen replacement therapy Premarin, increases the growth of neurons from the cerebral cortex. Presented at the Fifth International Conference on Alzheimer's disease; 1996; Osaka, Japan.
53. Berg L, Hughes CP, Cohen LA, et al. Mild senile dementia of the Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962-968.
54. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease: the Tacrine Study Group. JAMA 1994; 271:85-91.
55. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46:1580-1584.